Phase II clinical trial of diaziquone in bronchogenic carcinoma

Cancer Treat Rep. 1985 Jul-Aug;69(7-8):921-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Aziridines / adverse effects
  • Aziridines / therapeutic use*
  • Azirines / therapeutic use*
  • Benzoquinones*
  • Carcinoma, Bronchogenic / drug therapy*
  • Carcinoma, Bronchogenic / secondary
  • Drug Evaluation
  • Humans
  • Lung Neoplasms / drug therapy*
  • Middle Aged

Substances

  • Antineoplastic Agents
  • Aziridines
  • Azirines
  • Benzoquinones
  • diaziquone